No Data
No Data
R&G PharmaStudies Co., Ltd.'s (SZSE:301333) Intrinsic Value Is Potentially 35% Above Its Share Price
Norsger (301333.SZ): cumulative buyback of 1.33% of shares.
On August 1st, Gelonhui announced that as of July 31, 2024, the company has repurchased a total of 1,278,400 shares of the company through a repurchase dedicated securities account in a centralized bidding transaction, accounting for approximately 1.33% of the company's current total share capital of 96,000,000 shares. The highest fill price was 43.15 yuan/share, the lowest fill price was 35.06 yuan/share, and the total trading amount was 49,567,973.00 yuan (excluding transaction fees). The implementation of the above-mentioned repurchase is in compliance with relevant laws and regulations as well as the company's established repurchase plan.
Norske (301333.SZ) plans to launch an employee stock ownership plan in 2024.
Norris Greig (301333.SZ) has issued a draft of the 2024 employee stock ownership plan for participation by employees...
The shareholders of Nordisk (301333.SZ), Harmony Growth Phase II and Harmony Health did not reduce their shareholding at the end of the reduction period.
Northeast Securities (301333.SZ) announced that on July 22, 2024, the company received investment of the second phase of Harmonious Growth Fund and Harmonious ...
Norsgedge (301333.SZ): Has accumulated repurchased 1.28% of shares.
On July 19th, Gelonhui reported that up until July 19, 2024, Nosige (301333.SZ) had repurchased 1,228,300 shares of the company through a repurchase dedicated securities account using centralized bidding trading method, accounting for approximately 1.28% of the company's current total share capital of 96,000,000 shares. The highest fill price was 43.15 yuan/share, the lowest fill price was 35.06 yuan/share, and the total fill amount was 47.4204 million yuan (excluding transaction fees).
Why You Might Be Interested In R&G PharmaStudies Co., Ltd. (SZSE:301333) For Its Upcoming Dividend
No Data